When an insurance denial blocks guest writer Denise Schnieders from getting an MS disease activity test, she decides to fight back.

Researchers from Tr1x Inc. presented the development of TRX-319, a novel allogeneic regulatory T-cell therapy designed for the treatment of autoimmune disorders.

Intermountain Ventures is collaborating with a health tech startup to earlier identify cases of multiple sclerosis. The venture capital and innovation arm of Salt Lake City-based Intermountain Health ...

The court agreed on a block for early generics of a widely prescribed MS treatment, finding even though a psoriasis ...

Nicole Pedra is a disability advocate, influencer, actress and model who was diagnosed with multiple sclerosis at age 10, but chose to keep it private for two decades. In this episode of “Enable: The ...

About 1 million people are living with multiple sclerosis in the U.S., and about 10% of those have PPMS, making it the least common form of the disease.

Tolebrutinib failed to lower disability progression risk in primary progressive MS in a Phase 3 trial, with data shown at ...

Christina Applegate says she’s certain she contracted COVID at the packed Married With Children reunion and reflects on the ...

Investigators have identified patients who tested positive for the Epstein-Barr Virus 9 years after they were diagnosed with MS, challenging the prevailing notion that the virus precedes MS.

Applegate, who is partnering with pharmaceutical company TG Therapeutics on the site, invites others with MS to open up about "the good, the bad, the ugly, the in-betweens, the diapers, the things, ...

Are autoimmune diseases fatal? Normally, your immune system fights off disease and protects your body from infection. However, when you have an autoimmune disease, your immune system ...

Multiple sclerosis (MS) is a chronic disease of the central nervous system. MS disrupts the flow of information between the ...